We report the case of a heavily pretreated male subject affected by left funiculus liposarcoma and successfully treated with eribulin mesylate. After three surgical interventions, radiotherapy on the lesion of the penile bulb for satellite nodules and an epirubicin + ifosfamide chemotherapy treatment for six cycles, eribulin was administered at the dose of 1.1 mg/m on days 1 and 8, every 3 weeks for a total of nine cycles. A significant reduction of the lesions was achieved after four cycles of therapy, with a good profile of tolerability.
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient / Miano S.T.; Francini E.; Petrioli R.; Francini G.. - In: FUTURE ONCOLOGY. - ISSN 1479-6694. - STAMPA. - 16:(2020), pp. 33-38. [10.2217/fon-2019-0600]
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient
Francini E.Writing – Review & Editing
;
2020
Abstract
We report the case of a heavily pretreated male subject affected by left funiculus liposarcoma and successfully treated with eribulin mesylate. After three surgical interventions, radiotherapy on the lesion of the penile bulb for satellite nodules and an epirubicin + ifosfamide chemotherapy treatment for six cycles, eribulin was administered at the dose of 1.1 mg/m on days 1 and 8, every 3 weeks for a total of nine cycles. A significant reduction of the lesions was achieved after four cycles of therapy, with a good profile of tolerability.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Eribulin-induced liposarcoma regression case report.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
3.77 MB
Formato
Adobe PDF
|
3.77 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
